# Gastric Acid Suppression and Probiotic Colonization

> **NCT03327051** · PHASE4 · COMPLETED · sponsor: **Stanford University** · enrollment: 39 (actual)

## Conditions studied

- Probiotics

## Interventions

- **DRUG:** Omeprazole
- **DIETARY_SUPPLEMENT:** VSL #3
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03327051
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-20
- **Primary completion:** 2018-12-30
- **Final completion:** 2018-12-30
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2020-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03327051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03327051, "Gastric Acid Suppression and Probiotic Colonization". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03327051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*